EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

Scoping Review of Paediatric Population Pharmacokinetic Models of Morphine

Michael A Stokes iD, Noha A Kamel iD, Marino S Festa iD, Indy Sandaradura iD, Sophie L Stocker iD

Clinical Pharmacokinetics · 2025-06 · 64 (6) · 791-813

DOI: 10.1007/s40262-025-01477-5 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 01.05.2025. Verfasst von Michael A Stokes und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, A15 Pharmacy and Bank Building, Science Road, Camperdown, NSW, 2006, Au…. Hauptthemen laut MEDLINE: Morphine, Models, Biological, Analgesics, Opioid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE AND PURPOSE: This scoping review aimed to summarise all available population pharmacokinetic models of morphine and its metabolites (morphine-3-glucoronide [M3G], morphine-6-glucoronide [M6G]) in children and describe how morphine exposure varies across paediatric age groups and settings. Identifying the factors that contribute to pharmacokinetic variability may improve our understanding of a patient's pharmacodynamic response to morphine. METHODS: We searched Embase and MEDLINE databases from inception to 8 March 2024 for paediatric population pharmacokinetic models of morphine and its metabolites. Two reviewers independently screened abstracts and full texts and extracted the data. The review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. RESULTS: In total, 21 paediatric population pharmacokinetic models of morphine were identified; 12 studies also included morphine metabolites (M3G and/or M6G). Neonates and young children ( 6 years) and adolescents (> 10 years) were included in only 6 of the 21 (29%) models. Morphine pharmacokinetics were most commonly described with two-compartment (52%) and one-compartment (38%) structure with first-order elimination. Several model covariates were identified: bodyweight, post-natal age for neonates, body temperature, therapeutic cooling, duration of mechanical ventilation, and genetic variation in drug transporters that mediate the uptake of morphine (e.g. OCT1). CONCLUSION: Several population pharmacokinetic models of morphine and its metabolites in paediatrics have been published across diverse patient groups. Bodyweight and age-related covariates emerged as the most common factors affecting clearance and distribution; other covariates, including mechanical ventilation, therapeutic cooling, and genetic variation, also impacted morphine pharmacokinetics. Further research should focus on validating the predictive accuracy of paediatric morphine models in different patient populations and the combined effect of covariates, such as those related to critical illness and genetic variation, on morphine pharmacokinetics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MorphineModels, BiologicalAnalgesics, OpioidHumansChildAdolescentChild, PreschoolInfant, NewbornInfantAge FactorsMorphine Derivatives

Substanzen

MorphineAnalgesics, OpioidMorphine Derivatives

Autor:innen und Institutionen

  • School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, A15 Pharmacy and Bank Building, Science Road, Camperdown, NSW, 2006, Australia.
  • Kids Critical Care Research, Children's Hospital at Westmead, Westmead, NSW, Australia.
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, NSW, Australia.
  • Faculty of Medicine and Health, Westmead Clinical School, The University of Sydney, Sydney, NSW, Australia.
  • Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Sydney, NSW, Australia.

ORCID-Profile: Michael A Stokes, Noha A Kamel, Marino S Festa, Indy Sandaradura, Sophie L Stocker

Förderung

  • University of Sydney

Zitieren

APA

Stokes, M. A., Kamel, N. A., Festa, M. S., Sandaradura, I., & Stocker, S. L. (2025). Scoping Review of Paediatric Population Pharmacokinetic Models of Morphine. Clinical Pharmacokinetics, 64(6), 791-813. https://doi.org/10.1007/s40262-025-01477-5

Vancouver

Stokes MA, Kamel NA, Festa MS, Sandaradura I, Stocker SL. Scoping Review of Paediatric Population Pharmacokinetic Models of Morphine. Clinical Pharmacokinetics. 2025;64(6):791-813. doi:10.1007/s40262-025-01477-5

BibTeX
@article{Stokes2025,
  author = {Stokes, Michael A and Kamel, Noha A and Festa, Marino S and Sandaradura, Indy and Stocker, Sophie L},
  title = {Scoping Review of Paediatric Population Pharmacokinetic Models of Morphine},
  journal = {Clinical Pharmacokinetics},
  year = {2025},
  volume = {64},
  number = {6},
  pages = {791--813},
  doi = {10.1007/s40262-025-01477-5}
}
Kostenlos starten →